Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32310
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan Leerdam, Taylah R-
dc.contributor.authorZajac, Jeffrey D-
dc.contributor.authorCheung, Ada S-
dc.date2023-
dc.date.accessioned2023-03-22T01:49:20Z-
dc.date.available2023-03-22T01:49:20Z-
dc.date.issued2023-02-
dc.identifier.citationTransgender Health 2023; 8(1)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32310-
dc.description.abstractGender-affirming hormone therapy (GAHT) is an essential part of gender affirmation for many transgender (including people with binary and nonbinary identities) individuals and although controlled studies are unethical, there remains limited evidence on the impact of GAHT on gender dysphoria, quality of life (QoL), and psychological functioning. Some clinicians and policy makers use the lack of evidence to argue against providing gender-affirming care. The aim of this review is to systematically and critically assess the available literature on the influence of GAHT on improving gender- and body-related dysphoria, psychological well-being, and QoL. Using Preferred Reporting Items for Systematic Review and Meta-analysis guidelines, we searched Ovid MEDLINE®, Embase®, and Ovid PsycINFO® from inception to March 6, 2019 to assess the influence of GAHT on (1) gender dysphoria, (2) body uneasiness, (3) body satisfaction, (4) psychological well-being, (5) QoL, (6) interpersonal and global functioning, and (7) self-esteem. Our search strategy found no randomized controlled trials. Ten longitudinal cohort studies, 25 cross-sectional studies, and 3 articles reporting both cross-sectional and longitudinal data were identified. While results are mixed, the majority of studies demonstrate that GAHT reduces gender dysphoria, body dissatisfaction, and uneasiness, subsequently improving psychological well-being and QoL in transgender individuals. However, all current researches are of low to moderate quality comprising longitudinal cohort studies and cross-sectional studies, making it difficult to draw clear conclusions and do not reflect external social factors unaffected by GAHT, which significantly impact on dysphoria, well-being, and QoL.en_US
dc.language.isoeng-
dc.subjectgender dysphoriaen_US
dc.subjectgender identityen_US
dc.subjectgender-affirming hormone therapyen_US
dc.subjectmental healthen_US
dc.subjectquality of lifeen_US
dc.subjecttransgenderen_US
dc.titleThe Effect of Gender-Affirming Hormones on Gender Dysphoria, Quality of Life, and Psychological Functioning in Transgender Individuals: A Systematic Review.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleTransgender Healthen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.doi10.1089/trgh.2020.0094en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-0810-5961en_US
dc.identifier.orcid0000-0001-5257-5525en_US
dc.identifier.pubmedid36895312-
dc.description.volume8-
dc.description.issue1-
dc.description.startpage6-
dc.description.endpage21-
local.name.researcherCheung, Ada S
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.